Terry J. DuBose, M.S. - Chairman USA
Gregrio Lorenzo Accio, MS - Brazil
Joan P. Baker MSR - USA
David E. Blackwell, MD - USA
Professor Pavel Calda, MD, PhD - Czech Republic
Joshua Abbott Copel, MD - USA
Greggory R. DeVore, MD - USA
Jeffrey M. Dicke, MD - USA
Julia Drose, BA - USA
Arthur C. Fougner, MD - USA
David Ashley Hill, MD - USA
David Hutchon, BSc, MB, ChB, FRCOG Scotland
Alicia M. Lapidus, MD - Argentina
Edward A. Lyons, MD - Canada
Daniel Margulies, MD - Argentina
Martin Necas, RDMS, RVT - New Zealand
Wayne H. Persutte, BS, RDMS - USA
Lawrence David Platt, MD - USA
Cindy Rapp, RDMS - USA
Johannes Wilhelm 'Hans' van der Slikke, MD, PhD - Netherlands
James S Smeltzer, MD - USA
Ilan E. Timor-Tritsch, MD - USA
Master Sgt. Cheryl Vance, MA, RDMS, RVT - USA
Professor Anthony M. Vintzileos, MD - USA
Christopher Ross Welsh, MD, MRCOG - UK
Josef Wisser, MD - Switzerland
Joseph A Worrall MD RDMS - USA
Edward M. Zabrek, MD - USA
FDA adds boxed warning to fezolinetant for rare serious liver injury
Published: December 17th 2024 | Updated: December 17th 2024The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.
Read More